Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 2, 2014
A Rice University-led study in the June 1, 2014 issue of Nature Medicine reports the first preclinical tests for a novel anti-cancer technology called "quadrapeutics" that converts current clinical treatments to instantaneously detect and kill only cancer cells. Quadrapeutics combines clinically available drugs, colloidal gold, pulsed lasers and radiation in a novel and safe micro-treatment that improved standard therapy by 17-fold against aggressive, drug-resistant tumors.